Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer
2015 ◽
Vol 114
(2)
◽
pp. 161-166
◽
2013 ◽
Vol 73
(3)
◽
pp. 451-457
◽